Cardiovascular diseases (CVD) are responsible for a substantial portion of global health issues, with rising numbers of cases in both developed and developing nations. The challenges associated with CVD are multifaceted, involving a complex interplay of genetic, environmental, and socioeconomic factors. In many regions, limited access to quality healthcare and the increasing prevalence of risk factors like obesity, diabetes, and smoking contribute to the growing burden of heart disease. Tackling these global cardiovascular challenges demands innovative public health strategies that emphasize prevention, equitable access to care, and the education of populations about the importance of lifestyle modifications. Efforts at a global level to address these issues will play a key role in reducing the impact of CVD on health systems worldwide.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title :
Federico Benetti, Benetti Foundation, Argentina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation